Preclinical Research

 (narith_2527/iStock via Getty Images Plus)

People on the Move: October 2020

By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

(Image: Thermo Fisher)

Thermo Fisher expands cryo-EM access

By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

(monsitj/iStock via Getty Images Plus)

People on the Move: August 2020

By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

(HAKINMHAN/iStock via Getty Images Plus)

Latest FDA advice and actions on COVID-19

By Jenni Spinner

As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.

(April Thornberg/iStock via Getty Images Plus)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer advice for drug developers and other stakeholders, and to take action against companies that step out of line.

(Image: Getty/wildpixel)

Immunai unveils map of human immune system

By Jenni Spinner

A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

(Image: Getty/zubada)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer guidance about COVID-19 treatments and tests—and issue warnings to companies that fall out of line.

(Image: Getty/css0101)

FDA update on COVID-19 actions and advisements

By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

Follow us

Products

View more

Webinars